Psychotropic-Induced Weight Gain: Liability, Mechanisms and Treatment Approaches
- 1 January 2006
- book chapter
- Published by Informa UK Limited
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophreniaLife Sciences, 2004
- Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeksClinical Therapeutics, 2002
- Evidence for the involvement of dopamine D1 and D2 receptors in mediating the decrease of food intake during repeated treatment with amphetamineJournal of Biomedical Science, 2001
- Up‐regulation of uncoupling proteins by β‐adrenergic stimulation in L6 myotubesFEBS Letters, 2001
- Safety and efficacy of vigabatrin and carbamazepine in ne wly diagnosed epilepsy: a multicentre randomised double-blind studyThe Lancet, 1999
- Dopamine Receptor Subtype Agonists and Feeding BehaviorObesity Research, 1995
- Serotonin, Eating Behavior, and Fat IntakeObesity Research, 1995
- Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptorsNature, 1995
- Imipramine and weight gain during the treatment of recurrent depressionJournal of Affective Disorders, 1990
- Weight Changes With Schizophrenic Psychosis and Psychotropic Drug TherapyPsychosomatics, 1970